Ana Blanca

Universidad de Córdoba

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Stefan Salcher

Medical University of Innsbruck

AUSTRIA

View details

Antonio Lopez-Beltran

Universidad de Córdoba

SPAIN

View details

Maria Frantzi

GERMANY

View details

Rodolfo Montironi

Molecular Medicine and Cell Therapy Foundation, Polytechnic University of the Marche Region, Italy

ITALY

View details

Liang Cheng

Indiana University School of Medicine

UNITED STATES

View details

Isabel Heidegger

Medical University of Innsbruck

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ana Blanca

Research Interests

Explore related searches

Contact this professor

Articles (10)

Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer

Aberrant E-cadherin Expression in Lobular Carcinoma In Situ

Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature.

Multi-Centre Study of Progression Factors and Intravesical Recurrence in Patients with Urothelial Carcinoma of the Upper Urinary Tract

Giant cell carcinoma of the urinary bladder

Predictive and prognostic biomarkers in urological tumours

Validation of a Urine-Based Proteomics Test to Predict Clinically Significant Prostate Cancer: Complementing mpMRI Pathway

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination

Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward.

Collaborators (6)

Stefan Salcher

Antonio Lopez-Beltran

Maria Frantzi

Rodolfo Montironi

Liang Cheng

Isabel Heidegger

Make your next move.